S. Vignot

发表

Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.

D. Khayat, G. Milano, J. Spano, 2008, Critical reviews in oncology/hematology.

S. Lantuejoul, F. André, J. Soria, 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

N. Magné, J. Blay, J. Thariat, 2016 .

A step in the journey of denosumab from bone-targeted therapy to seed- and soil-targeted therapy.

D. Khayat, S. Vignot, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Radiation therapy in inflammatory breast cancer].

J. Thariat, C. Lévy, S. Vignot, 2018, Bulletin du Cancer.

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority

S. Vignot, M. Echemann, P. Maison, 2022, Frontiers in Pharmacology.

Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer

A. Duval, F. Coulet, J. Godet, 2021, ESMO open.

Reduction in HER-2 protein expression in a breast tumor HER-2 positive after only one injection of Trastuzumab: a case report

H. Errihani, S. Vignot, H. Mrabti, 2009, Cases journal.

Outcome of HER2-positive breast cancer patients following metastatic relapse after adjuvant trastuzumab treatment since EMA regulatory approval.

C. Genestie, D. Khayat, J. Spano, 2012 .

Advances in Brief Regulation of Extracellular Matrix Metalloproteinase Inducer and Matrix Metalloproteinase Expression by Amphiregulin in Transformed Human Breast Epithelial Cells

M. Serova, F. Calvo, S. Mourah, 2003 .

Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review.

J. Thariat, E. Barranger, B. Cutuli, 2018, Anticancer research.

A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).

J. Thariat, P. Marcy, S. Testelin, 2014, Critical reviews in oncology/hematology.

[Radiation-induced bronchiolitis obliterans with organizing pneumonia].

J. Thariat, P. Marcy, A. Lacout, 2017, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[HBV infection: Screening and treatment for oncology patients].

Y. Merrouche, L. D'alteroche, A. Landau, 2018, Bulletin du cancer.

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

N. Mounier, P. Chérel, M. Janvier, 2005, Clinical lymphoma.

mTOR-targeted therapy of cancer with rapamycin derivatives.

E. Raymond, S. Faivre, E Raymond, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus

S. Vignot, T. de la Motte Rouge, J. Hadoux, 2010, Clinical Medicine Insights. Oncology.

Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.

Céline Lefebvre, Jean-Philippe Spano, Frédérique Capron, 2015, European journal of cancer.

Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.

F. André, J. Soria, B. Besse, 2012, Critical reviews in oncology/hematology.

Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer

G. Scagliotti, S. Novello, D. Khayat, 2011, Cancer.

Molecular analysis for refractory rare cancers: sequencing battle continues: learnings for the MOSCATO-01 study.

S. Michiels, G. Malouf, A. Hollebecque, 2022, Critical reviews in oncology/hematology.

Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.

Elisabeth Brambilla, Stéphane Vignot, Roman Yelensky, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

Philip J. Stephens, Doron Lipson, Jean-Charles Soria, 2018, PLoS Comput. Biol..

Integrating genomics in head and neck cancer treatment: Promises and pitfalls.

J. Thariat, G. Milano, E. Van Obberghen-Schilling, 2015, Critical reviews in oncology/hematology.

[American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].

J. Blay, J. Thariat, J. Bay, 2011, Bulletin du cancer.

[Lung cancer: an update in 2010].

J. Soria, B. Besse, S. Vignot, 2010, Bulletin du cancer.

[FGF/FGFR signalling: Implication in oncogenesis and perspectives].

N. Magné, R. Flippot, S. Vignot, 2015, Bulletin du cancer.

Biomarkers of response to immunotherapy in early stage non-small cell lung cancer.

N. Chaput, B. Besse, L. Mezquita, 2023, European journal of cancer.

[Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].

S. Vignot, S. Watson, C. Serrate, 2010, Bulletin du cancer.

Pharmacokinetics of sunitinib in hemodialysis.

G. Milano, M. Etienne-Grimaldi, H. Izzedine, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[Obesity and cancer].

J. Thariat, Y. Merrouche, S. Vignot, 2017, Bulletin du cancer.

[Implications of ALK (anaplastic lymphoma kinase) in oncohematology].

N. Mounier, T. Cluzeau, S. Vignot, 2010, Bulletin du cancer.

Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells.

Fabien Calvo, M. Serova, F. Calvo, 2003, Cancer research.

Point sur les cancers du poumon en 2010

J. Soria, B. Besse, S. Vignot, 2010 .

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer.

M. Mathieu, F. André, M. Spielmann, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bronchial endoscopic ultrasound elastography: preliminary feasibility data

T. Similowski, F. Capron, F. Jeny, 2013, European Respiratory Journal.

[Non oncologic applications of molecular targeted therapies].

Jean-Christophe Amirault, S. Vignot, Wassef Khaled, 2012, Bulletin du cancer.

Mechanisms of phosphenes in irradiated patients

J. Thariat, J. Herault, L. Kodjikian, 2017, Oncotarget.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.

GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma

D. Khayat, J. Spano, L. Leenhardt, 2012, Medical Oncology.

Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort

A. Fourrier-Réglat, F. Tubach, J. Prevost, 2019, British Journal of Cancer.

Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

J. Emmerich, P. Maison, S. Vignot, 2021, Frontiers in Pharmacology.

[Anemia and colorectal cancer].

J. Spano, S. Vignot, 2005, Bulletin du cancer.

Mobile applications in oncology: is it possible for patients and healthcare professionals to easily identify relevant tools?

Nicolas Mounier, Stéphane Vignot, N. Mounier, 2016, Annals of medicine.

Cannabis et cancer

B. Besse, J. Spano, L. Karila, 2006 .

Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience

G. Noël, J. Mazeron, S. Vignot, 2002 .

[Melanomas of the female genital tract: state of the art].

N. Magné, R. Rivoirard, C. Chauleur, 2014, Bulletin du cancer.

[Prognostic and predictive factors in lung cancer].

B. Besse, S. Vignot, H. Marijon, 2009, Bulletin du Cancer.

[Improvements of ablative local treatments modify the management of the oligometastatic disease].

J. Thariat, F. Mornex, R. Bensadoun, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Bone targeted therapies: new agents].

C. Massard, S. Vignot, C. Barth, 2013, Bulletin du Cancer.

[Histone deacetylase inhibitors: highlight on epigenetic regulation].

N. Mounier, T. Cluzeau, C. Thibault, 2010, Bulletin du cancer.

Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).

P. Stephens, R. Yelensky, M. Cronin, 2012 .

Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer

G. Scagliotti, S. Novello, D. Khayat, 2011, Cancer.

[2015 through the eyes of the Bulletin of Cancer editorial board].

N. Magné, J. Blay, J. Thariat, 2016, Bulletin du cancer.

[Discrepancies between primary tumor and metastasis: impact on personalized medicine].

J. Soria, J. Soria, S. Vignot, 2013, Bulletin du cancer.

Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.

F. André, J. Soria, B. Besse, 2012, Critical reviews in oncology/hematology.

[The breakthrough of personalized medicine, new hopes and new challenges].

A. Schernberg, R. Flippot, L. Verlingue, 2017, Bulletin du cancer.

[American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].

J. Blay, J. Thariat, J. Bay, 2011, Bulletin du cancer.

[Nivolumab, a new hope in non-small cell lung cancer].

B. Besse, R. Flippot, M. Wislez, 2015, Bulletin du cancer.

[Bone targeted therapies: new agents].

C. Massard, C. Massard, S. Vignot, 2013, Bulletin du cancer.